Join this live virtual discussion as expert panelists share their experiences and perspectives on NMR-based human metabolomics in the diverse application areas of nutrition, oncology and pediatrics.

Human metabolomics has seen a rapid rise in the world of omics and is currently a major source of funding in many countries worldwide.  During this live virtual panel, three expert researchers, using various applications of Human Metabolomics research, will address the four topics below and take questions from the audience:

  1. How has COVID-19 has affected your research?
  2. What makes fund proposals more successful, and how do you obtain funds for your research in Human Metabolomics?
  3. What are the specific challenges in your research area?
  4. The future of NMR based Human Metabolomics Research

Read more about the panelists below to learn more about their work and submit your questions for them on the registration form.


Chair in Nutrition and Dietetics
Imperial College London

Gary is currently head of the Section for Nutrition Research and leads the Imperial Nutrition and Food Network. He qualified as a dietitian in 1982 and has always maintained a clinical input throughout his career. Gary worked at Hammersmith Hospital for 18 years; over this time, he gained his PhD in Nutrition and was appointed Honorary Reader in Nutrition at Imperial College, then joined the University of Surrey as Professor of Nutrition and Dietetics in 2005. Gary was appointed to Professor of Nutrition and Dietetics at Imperial College in 2008.

Head Professor
Department of Circulation and Medical Imaging
Norwegian University of Science and Technology

As head of the MR Cancer Group, Bathen’s main research interests are focused on personalized medicine and studies of functional and metabolic properties of cancer, using magnetic resonance imaging (MRI) and spectroscopy (MRS). By developing, optimizing, and applying advanced MR (in combination with other molecular methods) to characterize cancer, the group’s goal is to establish better diagnostic tools for the stratification of patients to treatment and treatment monitoring. Current research activities mainly focus on breast and prostate cancer, enabled by a close collaboration with St. Olav’s University Hospital in Trondheim. Although clinical research has high priority, the broad spectrum of systems for cancer studies provides translational research, covering ex vivo as well as in vivo MRI and MRS of cancer cells and laboratory animals. Bathen’s group also maintains several large biobanks of human tissue and biofluid samples.

Principal Investigator
Precision Medicine and Metabolism

Dr. Oscar Millet is the group leader of the Precision Medicine and Metabolism group of the CIC bioGUNE. His research focuses on the use of nuclear magnetic resonance (NMR) in the study of biologically relevant proteins and enzymes, paying special attention to the metabolic information that can be extracted from biological samples such as serum and urine. He has been awarded the Real Sociedad Española de Química prize (2004), the Spanish NMR group prize (2005), and the Innovation Award of the Basque Government (2018). He is the scientific founder of the spin-off Atlas Molecular Pharma and is the president of the Spanish Chemical Biology Group.

Webinar Host

Bruker Corporation

Bruker offers preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, neuroimaging and cardiac disease.

Additional Content From Bruker Corporation

Related Content